Volume-based parameter of 18F-FDG PET/CT in malignant pleural mesothelioma: Prediction of therapeutic response and prognostic implications

Annals of Surgical Oncology

Volumn 17, Issue 10, 2010, Pages 2787-2794

  Lee, Ho Yun ^a   Hyun, Seung Hyup ^a   Lee, Kyung Soo ^a   Kim, Byung Tae ^a   Kim, Jhingook ^a   Shim, Young Mog ^a   Ahn, Myung Ju ^a   Kim, Tae Sung ^a   Yi, Chin A ^a   Chung, Myung Jin ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYANOCOBALAMIN; FLUORODEOXYGLUCOSE F 18; FOLIC ACID; PEMETREXED;

ADULT; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; LUNG SURGERY; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PLEURA MESOTHELIOMA; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PROGNOSIS; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR VOLUME; VITAMIN SUPPLEMENTATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; PLEURAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78049470740     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1107-z     Document Type: Article

References (25)

1. J Peto A Decarli C La Vecchia F Levi E Negri 1999 The European mesothelioma epidemic Br J Cancer. 79 666 667 1:STN:280:DyaK1M7kvFGqsQ%3D%3D 10.1038/sj.bjc.6690105 10027347
2. BWS Robinson RA Lake 2005 Advances in malignant mesothelioma N Engl J Med. 353 1591 1603 1:CAS:528:DC%2BD2MXhtFWhur7O 10.1056/NEJMra050152 16221782
3. S Mirvis JP Dutcher PJ Haney NO Whitley J Aisner 1983 CT of malignant pleural mesothelioma AJR Am J Roentgenol. 140 665 670 1:STN:280: DyaL3s7nsFajtA%3D%3D 6601367
4. A Kawashima HI Libshitz 1990 Malignant pleural mesothelioma: CT manifestations in 50 cases AJR Am J Roentgenol. 155 965 969 1:STN:280: DyaK3M%2Fit1alsQ%3D%3D 2120965
5. RT Heelan VW Rusch CB Begg DM Panicek JF Caravelli C Eisen 1999 Staging of malignant pleural mesothelioma: comparison of CT and MR imaging AJR Am J Roentgenol. 172 1039 1047 1:STN:280:DC%2BD3c%2Flt1ChtQ%3D%3D 10587144
6. SG Armato JL Ogarek A Starkey NJ Vogelzang HL Kindler M Kocherginsky H MacMahon 2006 Variability in mesothelioma tumor response classification AJR Am J Roentgenol. 186 1000 1006 10.2214/AJR.05.0076 16554570
7. 18F-FDG PET scans J Nucl Med. 48 1449 1458 10.2967/jnumed.107.042333 17704250
8. F Monetti S Casanova A Grasso MA Cafferata A Ardizzoni CE Neumaier 2004 Inadequacy of the new response evaluation criteria in solid tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases Lung Cancer. 43 71 74 1:STN:280:DC%2BD2c%2FgtlWlsw%3D%3D 10.1016/j.lungcan.2003.07.005 14698539
9. RJ van Klaveren JGJV Aerts H de Bruin G Giaccone C Manegold JP van Meerbeeck 2004 Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma Lung Cancer. 43 63 69 10.1016/S0169-5002(03)00292-7 14698538
10. MJ Byrne AK Nowak 2004 Modified RECIST criteria for assessment of response in malignant pleural mesothelioma Ann Oncol. 15 257 260 1:STN:280:DC%2BD2c%2FlvVamtg%3D%3D 10.1093/annonc/mdh059 14760119
11. SG Armato GR Oxnard H MacMahon NJ Vogelzang HL Kindler M Kocherginsky, et al. 2004 Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques Med Phys. 31 1105 1115 10.1118/1.1688211 15191298
12. SG Armato III GR Oxnard M Kocherginsky NJ Vogelzang HL Kindler H MacMahon 2005 Evaluation of semi-automated measurements of mesothelioma tumor thickness on CT scans Acad Radiol. 12 1301 1309 10.1016/j.acra.2005.05.021 16179207
13. BH Kwek SL Aquino AJ Fischman 2004 Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis Chest. 125 2356 2360 10.1378/chest.125.6.2356 15189963
14. VW Rusch 1995 A proposed new international TNM staging system for malignant pleural mesothelioma. From The International Mesothelioma Interest Group Chest. 108 1122 1128 1:STN:280:DyaK28%2FhtVWktA%3D%3D 10.1378/chest.108.4. 1122 7555126
15. TD Yan M Boyer MM Tin PG Bannon BC McCaughan 2009 Prognostic features of long-term survivors after surgical management of malignant pleural mesothelioma Ann Thorac Surg. 87 1552 1556 10.1016/j.athoracsur.2009.01.026 19379903
16. SS Shim KS Lee B-T Kim MJ Chung EJ Lee J Han, et al. 2005 Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging Radiology. 236 1011 1019 10.1148/radiol.2363041310 16014441
17. RL Wahl H Jacene Y Kasamon MA Lodge 2009 From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors J Nucl Med. 50 122S 150S 1:CAS:528:DC%2BD1MXmtFahtr8%3D 10.2967/jnumed.108.057307 19403881
18. SH Hyun JY Choi YM Shim K Kim SJ Lee YS Cho, et al. 2010 Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma Ann Surg Oncol. 17 115 122 10.1245/s10434-009-0719-7 19826877
19. HC Steinert MMS Dellea C Burger R Stahel 2005 Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imaging Lung Cancer. 49S 1 S33 S35 10.1016/j.lungcan.2005.03.006
20. GL Ceresoli A Chiti PA Zucali M Rodari RF Lutman S Salamina, et al. 2006 Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose J Clin Oncol. 24 4587 4593 10.1200/JCO.2006.06.8999 17008700
21. P Veit-Haibach NG Schaefer HC Steinert JD Soyka B Seifert RA Stahel 2010 Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma Lung Cancer. 67 311 317 10.1016/j.lungcan.2009.04.015 19482372
22. 18FDG PET Methods Mol Med. 111 417 440 1:CAS:528: DC%2BD2MXkt1CqsbY%3D 15911993
23. R Boellaard NC Krak OS Hoekstra AA Lammertsma 2004 Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study J Nucl Med. 45 1519 1527 15347719
24. JW Keyes Jr 1995 SUV: standard uptake or silly useless value? J Nucl Med. 36 1836 1839 7562051
25. M Westerterp J Pruim W Oyen O Hoekstra A Paans E Visser, et al. 2007 Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters Eur J Nucl Med Mol Imaging. 34 392 404 10.1007/s00259-006-0224-1 17033848